Different sampling time points and Blinding [Bioanalytics]

posted by Pharma_88 – India, 2020-12-11 06:22 (1218 d 06:08 ago) – Posting: # 22138
Views: 2,330

Dear all,

Please provide your suggestion for below concern.

for the bioequivalence studies, Analyst is always blind despite of regulatory requirement. By keeping different sampling time points i.e. 20 time-points for test and 22 time points for reference, whether analyst will blind in this condition?


Edit: Category changed; see also this post #1[Helmut]

Complete thread:

UA Flag
Activity
 Admin contact
22,979 posts in 4,821 threads, 1,659 registered users;
35 visitors (0 registered, 35 guests [including 12 identified bots]).
Forum time: 13:31 CEST (Europe/Vienna)

Never, never, never use any software!
Never, never, never trust any computer!    Detlew Labes

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5